Disease & Drugs
by Team Pharmacally
A New Hope Against Antibiotic Resistance: Dual Mechanism in Chlorotonils Identified
Written By: Pragati Ekamalli, B.PharmReviewed By: Vikas Londhe M.Pharm (Pharmacology) IntroductionThe increase of pathogens t ...
Scientists Discover Lariocidin, a Potent Lasso Shaped Antibiotic in Garden Soil
Written By: Lavanya Chavhan B.PharmReviewed by Vikas Londhe M.Pharm (Pharmacology) In a remarkable twist of scientific serend ...
FDA expand drug label of ALK’s Odactra for the Treatment of House Dust Mite Allergy in Young Children
Written By Lavanya Chavhan B.PharmReviewed and Fact Checked by Vikas Londhe, M.Pharm (Pharmacology) The U.S. Food and Drug Ad ...
FDA Approves Qfitlia: First siRNA Therapy for Haemophilia Prophylaxis
Written by Aishwarya Shinde (B.Pharm)Reviewed and Fact Checked by Vikas Londhe M.Pharm (Pharmacology) The U.S. Food and Drug ...
EMA Approves Welireg (Belzutifan): A Breakthrough for VHL-Associated Tumors and Advanced Kidney Cancer
Written By Yogita Bhadane, B.Pharm Reviewed and Fact Checked by Vikas Londhe M.Pharm (Pharmacology) IntroductionWelireg (belz ...
Earth Day Spotlight: How Ecopharmacovigilance Protects the Planet from Pharmaceutical Pollution
Medically Written and Reviewed by Vikas Londhe M.Pharm (Pharmacology) As we honour Earth Day and reflect on our collective du ...
Could High-Dose Vitamin D Help Fight Early Multiple Sclerosis? New Evidence Says Yes
Written and Reviewed by Vikas Londhe M.Pharm (Pharmacology) A recent study published in JAMA on March 10, 2025, titled "High ...
FDA Approves Blujepa: First-in-Class Topoisomerase Inhibitor Antibiotic for UTIs
Written by Lavanya Chavhan (B.Pharm) and Aishwarya Shinde (B.Pharm)Reviewed and Fact Checked by Vikas Londhe M.Pharm (Pharmacology) ...
VykaT XR (Diazoxide Choline) Gets FDA Approval for Prader-Willi Syndrome-Related Hyperphagia
Written by Pavan Reddy (Biomedical Engineer) and Pragati Ekamalli (B.Pharm)Reviewed and Fact Checked by Vikas Londhe M.Pharm (Pharmacology) ...
No More Implants? Lab-Grown Teeth Might Be the Future of Dentistry
Written By Yogita Bhadane B.PharmReviewed and Fact Checked By Vikas Londhe M.Pharm (Pharmacology) Lost tooth has been a chall ...
“Age-Related Macular Degeneration: What’s New in Treatment and Research?”
Medically Reviewed by Dr. Mayur Jawale (MBBS, MS- Ophthalmology, Fellowship in Phacoemulsification) Introduction Age-related ...
Precision Oncology Advancements: Where We Stand Today
Written and Reviewed by Team Pharmacally Precision oncology, a rapidly expanding discipline of medicine, focuses on personali ...
A Harvard Medical School researcher may be able to improve diagnosis and care by personalizing patient’s complete blood count test: A move in the direction of precision medicine
Written and Reviewed by Team Pharmacally The Harvard Medical School researchers' study at Massachusetts General Hospital show ...
One Test, 18 Types of Cancers: Novelna’s Groundbreaking Approach to Early Cancer Diagnosis
Written and Reviewed by Team Pharmacally Many cancers found in the early stages (Stage I or II) show much better survival rat ...
An Update on mRNA Cancer Vaccines: A New Frontier in Oncology
Written and Reviewed by Team Pharmacally With promising results from early-phase clinical trials and ongoing developments, mR ...
The Mitochondrial Heist: How Cancer Cells Hijack Immune Cells to Evade Destruction
Written and Reviewed by Team Pharmacally Recent research from the Chiba Cancer Center Research Institute in Chiba, Japan, pub ...
BrECADD: A Modern Approach to Advanced-Stage Classical Hodgkin Lymphoma Treatment
Written and Reviewed by Team Pharmacally Classically, Hodgkin lymphoma (cHL) is highly treatable, yet its treatment for advan ...
Designed by Intelligence: AI-Engineered Proteins Revolutionize Antivenom Science
Written and Reviewed by Team Pharmacally Researchers led by Timothy Patrick Jenkins, PhD, from the Technical University of De ...
Jazz Pharmaceuticals reports that Ziihera® (zanidatamab-hrii) has received FDA for the treatment of adults with HER2-positive (IHC 3+) biliary tract cancer (BTC) that has been previously treated and is either incurable or metastatic
Written and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) gave Ziihera® (zanidatamab-hrii) expedit ...
Zepbound Cleared by FDA for Moderate to Severe Sleep Apnea in Obese Populations
Written and Reviewed by Team Pharmacally Zepbound (tirzepatide), the first drug approved by the U.S. Food and Drug Administra ...
A First-in-Class Sodium Channel Blocker for Acute Pain: FDA Approves Vertex’s JOURNAVX™ (suzetrigine) after 25 years of last approved pain killer
Written and Reviewed by Team Pharmacally The US Food and Drug Administration (FDA) have sanctioned Vertex Pharmaceuticals JOU ...
Artificial Intelligence in Medicine: Revolutionizing Healthcare
Written and Reviewed by Team Pharmacally Healthcare is one of the many areas that artificial intelligence (AI) is quickly cha ...
Seven-Minute Cancer Treatment Shot: Revolutionizing Oncology with Atezolizumab
Written and Reviewed by Team Pharmacally In a groundbreaking development, the introduction of a seven-minute cancer treatment ...
FDA Approval of Ryoncil (Remestemcel-L): A New Frontier in Regenerative Medicine
Written and Reviewed by Team Pharmacally Mesoblast Limited's mesenchymal stem cell therapy, Ryoncil (Remestemcel-L), was rece ...
FDA Approves Penmenvy, the First Pentavalent Vaccine for Comprehensive Invasive Meningococcal Disease Prevention
Written and Reviewed by Team Pharmacally Breakthrough Immunization Covers Five Major Serogroups, Simplifying Protection again ...
First Non-prescription Daily Oral Contraceptive: Opill
Written and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) approved Opill, the first daily oral con ...
FDA Approves Onapgo (Apomorphine Hydrochloride) for Treating Motor Fluctuations in Advanced Parkinson’s disease
Written and Reviewed by Team Pharmacally IntroductionThe U.S. Food and Drug Administration (FDA) has recently given the green ...
A New Hope for Crohn’s Patients: Eli Lilly’s Omvoh Gains FDA Approval”
Written and Reviewed by Team Pharmacally On January 15, 2025, the U.S. Food and Drug Administration (FDA) granted approval to ...
Breaking Barriers in Lung Cancer Treatment: The Impact of Lorlatinib
Written and Reviewed by Team Pharmacally Lung cancer is one of the most prevalent and deadly forms of cancer worldwide. Despi ...
A New Development in Immunotherapy for the Treatment of Nasopharyngeal Carcinoma: FDA Approves LOQTORZI
Written and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) has approved LOQTORZI (generic name: Lac ...
Breaking Barriers in Breast Cancer: Enhertu Shows Promise for HER2-Low Patients
Written and Reviewed by Team Pharmacally For patients with HER2-low breast cancer, the medication Enhertu (fam-trastuzumab de ...
EMA Grants Marketing Authorization for Emcitate (Tiratricol) for Peripheral Thyrotoxicosis in MCT8 Deficiency (Allan-Herndon-Dudley Syndrome)
Written and Reviewed by Team Pharmacally IntroductionThe European Medicines Agency (EMA) has recently approved Emcitate (tira ...
AbbVie’s Emblaveo Receives FDA Approval for Treating Complicated Intra-Abdominal Infections
Written and Reviewed by Team Pharmacally AbbVie, a leading company in the biopharmaceutical sector, has announced that the U. ...
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) for Menkes Disease
Written and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) have accepted Sentynl Therapeutics' New ...
Bavarian Nordic’s Chikungunya Vaccine “Vimkunya” Receives Landmark EMA and FDA Approval for Ages 12+
Written and Reviewed by Team Pharmacally Bavarian Nordic A/S, a prominent biotechnology firm focused on vaccine development, ...
CASGEVY: Revolutionizing Gene Therapy with CRISPR Technology to treat Transfusion-Dependent Beta Thalassemia
Written and Reviewed by Team Pharmacally IntroductionCasgevy (exagamglogene autotemcel) is a breakthrough in gene therapy and ...
Merus’s Bizengri: A Breakthrough finding in metastatic or advanced non-small cell lung cancer (NSCLC) and advanced unresectable or metastatic pancreatic adenocarcinoma
Written and Reviewed by Team Pharmacally Bizengri, created by Merus N.V., is a potential development in the fast developing f ...
“Bleeding No More: FDA Approval of Alhemo Signals Hope for Haemophilia Patients”
Written and Reviewed by Team Pharmacally The US FDA has granted approval for the Alhemo (concizumab-mtci) injection to be adm ...
Eli Lilly’s Zepbound: A New Frontier in Weight Loss Treatment
Written and Reviewed by Team Pharmacally Eli Lilly's Zepbound (tirzepatide) has shown remarkable success in clinical trials, ...
World’s First Type 1 Diabetes Reversal Using Stem Cell Therapy: a Breakthrough in Medical Science
Written and Reviewed by Team Pharmacally In a remarkable advancement, a 25-year-old woman in China has made history as the fi ...
A groundbreaking study demonstrates how Ozempic may be used to treat chronic kidney disease
Written and Reviewed by Team Pharmacally According to a recent clinical trials study published in Nature Medicine, there is e ...
Phase II trials of the first-ever blood-stage malaria vaccine in children from Burkina Faso showed encouraging results
Written and Reviewed by Team Pharmacally One of the most deadly infectious illnesses in the world, malaria has long been a pr ...
EU’s CHMP Endorses Fixed-Dose Combination of Ivermectin/Albendazole for lymphatic filariasis and other Parasitic Infections under EU-M4all Program
Written and Reviewed by Team Pharmacally Collaboration with WHO and African Nations Marks Milestone in Fight against Neglecte ...
Monash University researcher team identified a connection between exposure of severe COVID-19 during pregnancy and its impact on DNA-methylation and neurodevelopment outcome in infants
Written and Reviewed by Team Pharmacally Researchers at Monash University have revealed the significant impact that severe CO ...
Ponsegromab Emerges as a Breakthrough Treatment for Cancer Cachexia: Clinical Trial Results Show Significant Promise
Written and Reviewed by Team Pharmacally Cancer cachexia is a serious condition marked by significant weight loss, muscle was ...
Biogen’s Higher-Dose Nusinersen in Phase 2/3 DEVOTE Study Shows Positive Results for Spinal Muscular Atrophy
Written and Reviewed by Team Pharmacally For the treatment of Spinal Muscular Atrophy (SMA), a rare and frequently debilitati ...
Can Semaglutide Curb Alcohol Cravings? New Research Says Yes
Written and Reviewed by Team Pharmacally A recent study conducted by Dr. Christian Hendershot at University of North Carolina ...